Find Research Projects — UTMB Health Research Expert Profiles

6,200 - 6,250 out of 6,667 results

A PROSPECTIVE OBSERVATIONAL STUDY TO EVALUATE PREDICTORS OF CLINICAL EFFECTIVENESS IN RESPONSE TO OMALIZUMAB
Calhoun, W.
3/27/14 → 3/26/17
Project: Other project
A prospective, natural history study to assess the occurrence of HPA-1a alloimmunization in women identified at higher risk for Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT)
Saade, G.
8/18/21 → 8/17/26
Project: Other project
A Preclinical Model of Peripubertal and Adult Visceral Hypersensitivity
Winston, J.
9/18/18 → 8/31/21
Project: Other project
A Preclinical Model of Peripubertal and Adult Visceral Hypersensitivity
Winston, J.
9/18/18 → 8/31/21
Project: Other project
A portable closed-loop fluid resuscitation system to promote critical care and warfighter survivability in the prolonged field care environment
Kramer, G.
12/1/17 → 12/1/19
Project: Other project
A portable closed-loop fluid resuscitation system to promote critical care and warfighter survivability in the prolonged field care environment
Kramer, G.
12/1/17 → 12/1/19
Project: Other project
APOL1 Long-Term Kidney Transplantation Outcomes-Consortium for the Responsible and Ethical Evaluation of Organ Donation (APOLLOCREED) Clinical Center
Mujtaba, M.
4/1/19 → 5/31/20
Project: Other project
APOL1 Long-Term Kidney Transplantation Outcomes-Consortium for the Responsible and Ethical Evaluation of Organ Donation (APOLLOCREED) Clinical Center
Mujtaba, M.
4/1/19 → 5/31/20
Project: Other project
A point of care diagnostic test for the detection of SARS-CoV-2 antigen
Aguilar, P.
8/15/20 → 11/11/20
Project: Other project
A point of care diagnostic test for the detection of SARS-CoV-2 antigen
Aguilar, P.
InBios International
8/15/20 → 11/11/20
Project: Other project
A Phase ll, Randomized, Double-Blind, Placebo Controlled Bronchoscopy Study to Evaluate The Effects Of Lebrikizumab on Airway Eosinophilic Inflamation in Patients With Uncontrolled Asthma On Inhaled Corticosteroids and a Second Controller Medication
Calhoun, W.
5/28/14 → 5/15/18
Project: Other project
A Phase ll, Randomized, Double-Blind, Placebo Controlled Bronchoscopy Study to Evaluate The Effects Of Lebrikizumab on Airway Eosinophilic Inflamation in Patients With Uncontrolled Asthma On Inhaled Corticosteroids and a Second Controller Medication
Calhoun, W.
5/28/14 → 5/15/18
Project: Other project
A Phase I Randomized Clinical Trial of In-Hospital and Post-Hospital Whey Protein vs. Low Quality Protein vs. Isocaloric Placebo Supplementation to Improve Recovery From Hospitalization in Older Adults
Volpi, E.
2/1/18 → 3/1/23
Project: Other project
A Phase I Randomized Clinical Trial of In-Hospital and Post-Hospital Whey Protein vs. Low Quality Protein vs. Isocaloric Placebo Supplementation to Improve Recovery From Hospitalization in Older Adults
Volpi, E.
2/1/18 → 3/1/22
Project: Other project
A Phase I Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, and Immunogenicity of Live-Attenuated Tetravalent Dengue Vaccine (V181) in Flavivirus-Naive and Flavivirus-Experienced Health Adults (MK-V181-001-01)
Rupp, R.
1/4/18 → 1/3/21
Project: Other project
A Phase I Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, and Immunogenicity of Live-Attenuated Tetravalent Dengue Vaccine (V181) in Flavivirus-Naive and Flavivirus-Experienced Health Adults (MK-V181-001-01)
Rupp, R.
1/4/18 → 1/3/21
Project: Other project
A PHASE III RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF PRM-151 IN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS
Duarte, A.
Roche Laboratories Inc.
12/10/20 → 11/30/23
Project: Other project
A phase III randomised, double-blind trial to evaluate efficacy and safety of once daily empagliflozin 10 mg compared to placebo, in patients with chronic Heart Failure with preserved Ejection Fraction (HFpEF).
Khalife, W.
10/17/17 → 10/16/21
Project: Other project
A phase III randomised, double-blind trial to evaluate efficacy and safety of once daily empagliflozin 10 mg compared to placebo, in patients with chronic Heart Failure with preserved Ejection Fraction (HFpEF).
Khalife, W.
10/17/17 → 4/30/22
Project: Other project
A PHASE III OPEN-LABEL EXTENSION STUDY TO EVALUATE LONG-TERM SAFETY AND EFFICACY OF PRM-151 IN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS (IPF)
Duarte, A.
12/8/21 → 12/7/26
Project: Other project
A Phase III Double Blind, Randomized, Multicenter, Controlled Study to Evaluate the Immunogenicity, Safety and Tolerability of VARIVAX New Seed Process (NSP) Administered Concomitantly with M-M-R II
Rupp, R.
4/30/14 → 5/1/16
Project: Other project
A Phase III Double Blind, Randomized, Multicenter, Controlled Study to Evaluate the Immunogenicity, Safety and Tolerability of VARIVAX New Seed Process (NSP) Administered Concomitantly with M-M-R II
Rupp, R.
4/30/14 → 5/1/16
Project: Other project
A Phase IIIB, Observer-Blind, Randomized, Placebo-Controlled, Multi-Center Study to Assess the Safety and Immunogenicity of GSK Meningococcal Group B Vaccine and 13-valent Pneumococcal Vaccine when Administered Concomitantly with Routine Vaccines to Heal
Rupp, R.
7/9/18 → 7/8/20
Project: Other project
A Phase IIIB, Observer-Blind, Randomized, Placebo-Controlled, Multi-Center Study to Assess the Safety and Immunogenicity of GSK Meningococcal Group B Vaccine and 13-valent Pneumococcal Vaccine when Administered Concomitantly with Routine Vaccines to Heal
Rupp, R.
7/9/18 → 7/8/20
Project: Other project
A Phase III, Randomized, Placebo-Controlled, Clinical Trial to Study the Safety and Immunogenicity of Three Consistency Lots and a high Dose Lot of rVSV-ZEBOV-GP (V920 Ebola Vaccine) in Healthy Adults
Rupp, R.
8/4/15 → 9/30/18
Project: Other project
A Phase III, Randomized, Placebo-Controlled, Clinical Trial to Study the Safety and Immunogenicity of Three Consistency Lots and a high Dose Lot of rVSV-ZEBOV-GP (V920 Ebola Vaccine) in Healthy Adults
Rupp, R.
8/4/15 → 9/30/18
Project: Other project
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Adaptive Design Study of the Efficacy, Safety, and Tolerability of a Single Infusion of MK-3415 (Human Monoclonal Antibody to Clostridium difficile toxin A), MK-6072 (Human Monoclonal Antibody to
Keiser, P.
12/1/12 → 11/1/14
Project: Other project
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Adaptive Design Study of the Efficacy, Safety, and Tolerability of a Single Infusion of MK-3415 (Human Monoclonal Antibody to Clostridium difficile toxin A), MK-6072 (Human Monoclonal Antibody to
Keiser, P.
12/1/12 → 11/1/14
Project: Other project
A Phase III, partially modified double-blind, randomized, parallel-group, active-controlled, multi-center study to compare the immunogenicity and describe the safety of MenACYW conjugate vaccine and MENVEO® when administered concomitantly with routine pe
Rupp, R.
5/2/18 → 5/1/21
Project: Other project
A Phase III, partially modified double-blind, randomized, parallel-group, active-controlled, multi-center study to compare the immunogenicity and describe the safety of MenACYW conjugate vaccine and MENVEO® when administered concomitantly with routine pe
Rupp, R.
5/2/18 → 5/1/23
Project: Other project
A Phase IIb, Randomized, Observer-Blind study to Describe the Safety, Tolerability, and Immunogenicity of MenABCWY Administered on Different Dosing Schedules in Healthy Adolescents
Rupp, R.
2/14/22 → 2/13/27
Project: Other project
A Phase IIb, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Multidose, 24-Week Study to Evaluate the Efficacy and Safety of Atacicept in Subjects With Systemic Lupus Erythematosus (SLE)
Gonzalez, E.
7/28/14 → 7/27/16
Project: Other project
A Phase IIb, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Multidose, 24-Week Study to Evaluate the Efficacy and Safety of Atacicept in Subjects With Systemic Lupus Erythematosus (SLE)
Gonzalez, E.
7/28/14 → 7/27/16
Project: Other project
A Phase IIa, two-part, randomised, multi-centre, multinational, double-blind, placebo-controlled, parallel group study to compare the efficacy and safety of BCT197 when added on to standard of care for the treatment of acute respiratory exacerbations o
Calhoun, W.
6/15/16 → 6/14/18
Project: Other project
A Phase IIa, two-part, randomised, multi-centre, multinational, double-blind, placebo-controlled, parallel group study to compare the efficacy and safety of BCT197 when added on to standard of care for the treatment of acute respiratory exacerbations o
Calhoun, W.
6/15/16 → 6/14/18
Project: Other project
A Phase II, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Efficacy, Safety, and Tolerability of MT-7117 in Subjects with Erythropoietic Protoporphyria
Anderson, K.
6/6/18 → 6/5/23
Project: Other project
A Phase II, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Efficacy, Safety, and Tolerability of MT-7117 in Subjects with Erythropoietic Protoporphyria
Anderson, K.
6/6/18 → 11/30/20
Project: Other project
A Phase II, Double-Blind, Randomized, Multicenter Trial to Evaluate the Safety, Tolerability, and Immunogenicity of V114 Compared to Prevnar13¿ in Healthy Infants
Rupp, R.
2/8/17 → 2/7/21
Project: Other project
A Phase II, Double-Blind, Randomized, Multicenter Trial to Evaluate the Safety, Tolerability, and Immunogenicity of V114 Compared to Prevnar13¿ in Healthy Infants
Rupp, R.
2/8/17 → 2/7/21
Project: Other project
A Phase II, Double-Blind, Randomized, Multicenter Trial to Evaluate the Safety, Tolerability, and Immunogenicity of V114
Wolffarth, M.
2/8/17 → 8/7/20
Project: Other project
A Phase II, Double-Blind, Randomized, Multicenter Trial to Evaluate the Safety, Tolerability, and Immunogenicity of V114
Wolffarth, M.
2/8/17 → 8/7/20
Project: Other project
A Phase 3 Study to Evaluate the Efficacy and Long-term Safety of SHR0302 for Induction, Maintenance Therapy in Subjects with Moderately to Severely Active Ulcerative Colitis.
Cohn, S.
1/19/22 → 1/18/27
Project: Other project
A Phase 3 Randomized, Observer-blind Study to Evaluate the Safety, Tolerability, and Immunogenicity of a Lyophilized Formulation of the Vaccine Candidate BNT162b2 Against COVID-19 in Healthy Adults 18 through 55 years of Age.
Rupp, R.
3/11/21 → 3/10/25
Project: Other project
A Phase 3 Randomized, Observer-blind Study to Evaluate the Safety, Tolerability, and Immunogenicity of a Lyophilized Formulation of the Vaccine Candidate BNT162b2 Against COVID-19 in Healthy Adults 18 through 55 years of Age.
Rupp, R.
Pfizer, Inc.
3/11/21 → 3/10/25
Project: Other project
A Phase 3 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of MEDI8897, a Monoclonal Antibody With an Extended Half-life Against Respiratory Syncytial Virus, in Healthy Late Preterm and Term Infants (MELODY)
Nguyen, D.
9/12/19 → 9/11/21
Project: Other project
A Phase 3 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of MEDI8897, a Monoclonal Antibody With an Extended Half-life Against Respiratory Syncytial Virus, in Healthy Late Preterm and Term Infants (MELODY)
Nguyen, D.
9/12/19 → 11/30/22
Project: Other project
A Phase 3 International, Multicenter, Open-label Study to Evaluate the Safety and Immunogenicity of 9vHPV Vaccine Administered as 2-dose Regimen with Extended Dosing Intervals in 9- to 14-Year Old Boys and Girls Compared with a Standard 3-dose Regimen
Rupp, R.
Merck Sharp & Dohme Corporation
12/22/20 → 12/21/25
Project: Other project
A PHASE 3, SINGLE-ARM TRIAL TO EVALUATE THE SAFETY AND IMMUNOGENICITY OF A 20-VALENT PNEUMOCOCCAL CONJUGATE VACCINE IN HEALTHY CHILDREN 15 MONTHS THROUGH 17 YEARS OF AGE
Rupp, R.
Pfizer, Inc.
1/4/21 → 1/3/23
Project: Other project
A Phase 3, Randomized, Observer-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Immunogenicity of mRNA-1647 Cytomegalovirus (CMV) Vaccine in Healthy Participants 16 to 40 Years of Age
Rupp, R.
2/11/22 → 2/10/27
Project: Other project
A Phase 3, Randomized, Observer-Blind, Placebo-Controlled, Group-Sequential Study to Determine the Immunogenicity and Safety of a Respiratory Syncytial Virus (RSV) f Nanoparticle Vaccine with Aluminium in Healthy Third-trimester Pregnant Woman; and Safet
Saade, G.
8/18/16 → 8/17/21
Project: Other project